← Dashboard
Oct 05, 2026 12:14 PM ET
Signal
FDA/Bio
FDA approves additional U.S. manufacturing capacity for Simlandi, Alvotech’s biosimilar to Humira
FDA approval adds US manufacturing capacity for Alvotech's Humira biosimilar Simlandi.
What changed
FDA approval adds US manufacturing capacity for Alvotech's Humira biosimilar Simlandi.
Why it matters
FDA approval adds US manufacturing capacity for Alvotech's Humira biosimilar Simlandi. — impact context not separately stored; see What changed.
Sources
seekingalpha
Related signals
In reversal, American Cancer Society urges routine prostate cancer screening →
PHASE 1 OF INDIA - US TRADE PACT HINGES ON SECTION 301 PROBE , OFFICIAL SAYS →
PITNEY BOWES OUTLINES PHASE 2 STRATEGIC REVIEW WHILE PUSHING NEAREST DEBT MATURITY TO MARCH 2029 - SEEKINGALPHA →